The aim of the webinar is to give participants basic information on MDR/XDR-TB program management, so they can organize a simple but comprehensive DR-TB program at their local setting. To participate visit the DR TB Training Network https://drtbnetwork.org/webinars and register for as many of the webinars as you would like.

100 Ukrainians with cotton sacks on their heads, as if condemned to death, lined into a living wall in front of the Cabinet, accompanied by beating of drums. All of them are patients with terminal illness - namely, hepatitis, tuberculosis, AIDS, and activists. Protesters wanted to show with this action that 44 000 Ukrainians are sentenced to death this year, because  funds for life-saving treatment haven’t been allocated yet.

Concentrations of the antimalaria drugs artemether and lumefantrine were sharply lower during rifampin-based anti-TB therapy in Ugandan adults with HIV. The researchers recommend avoiding simultaneous use of artemether-lumefantrine and rifampin.

15 April 2013 - Geneva - The Stop TB Partnership Secretariat is inviting nominations from individuals who are interested in serving as country or constituency representatives on the Coordinating Board.

15 April 2013 - Geneva - The World Health Organization (WHO) and the Stop TB Partnership today honoured Dr Jorge Sampaio, the former UN Secretary-General’s Special Envoy to Stop Tuberculosis, for his work to raise the profile of tuberculosis (TB) on the international agenda.

The World Health Organization, supported by the President's Emergency Plan for AIDS Relief (PEPFAR), convened a regional TB/HIV Implementation Workshop followed by the 18th Core Group meeting of the TB/HIV Working Group of the Stop TB Partnership from 10th – 12th April 2013 in Maputo, Mozambique. The event brought together more than 120 participants, comprising key international partners as well as regional and national HIV and TB stakeholders including community and civil society representatives from 14 countries in the African region. Countries represented included Botswana, Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Namibia, Nigeria, South Africa, Swaziland, Uganda, United Republic of Tanzania, Zambia, and Zimbabwe. The aim of the workshop was to review progress in implementation and promote strategies to increase access to early ART for people living with HIV and active TB and to accelerate the scale-up of the Three Is for HIV/TB in the African Region. Participants also shared best practices and identified priority actions for scaling up, and monitoring and evaluating the implementation of collaborative TB/HIV activities.

Tuberculosis costs the European Union EUR 750 million per year and the European region is home to the highest rates of multidrug-resistant TB in the world, accounting for nearly 20% of the global burden.

The report, written by the All-Party Parliamentary Group on Global Tuberculosis, identifies the main challenges facing the UK and the world in controlling drug-resistant strains of TB and makes constructive recommendations for how the UK can best focus its efforts.

Maputo, Mozambique – The regional meeting to scale up collaborative TB/HIV activities in Africa kicked off in Maputo last week with presentations scheduled for 14 African country representatives to share progress and challenges in confronting TB/HIV co-infection in the most highly impacted region of the world.

Tuberculosis (TB) rates are coming down, but not dropping fast enough to keep the world on track to meet the target of Stop TB Partnership: to eliminate TB by 2050 (less than 1 percent TB in population is referred to as elimination). "The current decline in TB rate is 2 percent globally every year" said  Dr Christian Lienhardt of WHO Stop TB Department at the 4th Union Asia Pacific Region Conference on Lung Health (APRC 2013) which recently concluded in Hanoi, Viet Nam.